Autor: |
Liang S; Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, USA., Jensen MP; Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, USA. Electronic address: jensenm@ohio.edu. |
Jazyk: |
angličtina |
Zdroj: |
Journal of inorganic biochemistry [J Inorg Biochem] 2024 Jul; Vol. 256, pp. 112551. Date of Electronic Publication: 2024 Apr 09. |
DOI: |
10.1016/j.jinorgbio.2024.112551 |
Abstrakt: |
The solvated iron(II) salt [Fe(NCMe) 6 ](BF 4 ) 2 (Me = methyl) is shown to be a bifunctional catalyst with respect to aziridination of styrene. The salt serves as an active catalyst for nitrene transfer from PhINTs to styrene to form 2-phenyl-N-tosylaziridine (Ph = phenyl; Ts = tosyl, -S{O} 2 -p-C 6 H 4 Me). The iron(II) salt also acts as a Lewis acid in non-coordinating CH 2 Cl 2 solution, to catalyze heterolytic CN bond cleavage of the aziridine and insertion of dipolarophiles. The 1,3-zwitterionic intermediate is presumably supported by interaction of the metal dication with the anion, and by resonance stabilization of the carbocation. Nucleophilic dipolarophiles then insert to give a five-membered heterocyclic ring. The result is a two-step cycloaddition, formally [2 + 1 + 2], that is typically regiospecific, but not stereospecific. This reaction mechanism was confirmed by conducting a series of one-step, [3 + 2] additions of unsaturated molecules into pre-formed 2-phenyl-N-tosylaziridine, also catalyzed by [Fe(NCMe) 6 ](BF 4 ) 2 . Relevant substrates include styrenes, carbonyl compounds and alkynes. These yield five-membered heterocylic rings, including pyrrolidines, oxazolidines and dihydropyrroles, respectively. The reaction scope appears limited only by the barrier to formation of the dipolar intermediate, and by the nucleophilicity of the captured dipolarophile. The bifunctionality of an inexpensive, earth-abundant and non-toxic catalyst suggests a general strategy for one-pot construction of heterocyclic rings, as demonstrated specifically for pyrrolidine ring formation. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.) |
Databáze: |
MEDLINE |
Externí odkaz: |
|